News
Category
-
Aclaris Therapeutics Announces Pricing of Initial Public Offering
October 9, 2015 -
Proteostasis Therapeutics Announces Presentation of Data For Its CFTR Amplifier for Cystic Fibrosis
October 9, 2015 -
Ultragenyx Announces Aceneuramic Acid Prolonged Release Marketing Authorization Application Filed and Accepted for Review by European Medicines Agency
October 2, 2015 -
Collaboration for Alzheimer’s Prevention: An Initiative to Advance Alzheimer’s Disease Research
October 1, 2015 -
Flywire acquires UK-based tuition start-up competitor
October 1, 2015 -
peerTransfer expands, rebrands as Flywire
September 28, 2015 -
Quartet Health founder and CEO Arun Gupta on tech driving collaboration in behavioral health
September 19, 2015 -
Kyruus Gets $25M More for “Moneyball” Approach to Doctors and Patients
September 18, 2015 -
Aclaris Therapeutics International and Rigel Pharmaceuticals Sign License Agreement for JAK Inhibitors to Treat Skin Disorders
September 9, 2015 -
Blueprint Medicines Receives FDA Authorization to Advance Novel Drug Candidate into Clinical Trial for Systemic Mastocytosis
September 9, 2015 -
Proteostasis Therapeutics, Inc. Raises $37 Million in Crossover Financing
September 8, 2015 -
Ultragenyx Presents Data on Patients With Cardiomyopathy Treated with UX007
September 1, 2015 -
Symbiomix Therapeutics Announces That The FDA Has Granted Fast Track Designation To Its Single-Dose Bacterial Vaginosis Therapy, SYM-1219
August 27, 2015 -
BlackRock Embraces Robo Finance Advice with Acquisition of FutureAdvisor
August 26, 2015 -
ViewRay Completes Private Placement, Raises Aggregate of $29.4Million
August 20, 2015 -
Tradier Offers An Alternative to Other Robo-Advisors with Build-Your-Own Digital Platform
August 19, 2015 -
Ironwood Advances Drug With Potential in ‘Huge Range of Diseases’
July 23, 2015 -
Adaptimmune Announces Interim Results from Pilot Trial of its Engineered NY-ESO T Cells
October 17, 2014 -
Fidelity Biosciences Leads Investment Into Avidity Nanomedicines
October 7, 2014